Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sernova Corp (SVA.TO)

Sernova Corp (SVA.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Sernova Corp 700 Collip Circle, The Stiller Centre Suite 114 London ON N6G 4X8 CAN

https://www.sernova.com P: 888-318-7062 F: 519-858-5142

Description:

Sernova Corp is a clinical-stage company developing products for the treatment of chronic debilitating diseases. The company is engaged in the research and development of its proprietary Cell Pouch and associated technologies including immune-protected therapeutic cells. The Cell Pouch is is a scalable, implantable medical device designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells, which then release proteins, hormones or other factors into the bloodstream for the long-term treatment of multiple chronic diseases such as type 1 diabetes, hypothyroid disease, and rare diseases such as hemophilia A.

Key Statistics

Overview:

Market Capitalization, $K 128,948
Shares Outstanding, K 303,408
Annual Sales, $ 0 K
Annual Net Income, $ -38,998 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -9,743 K
60-Month Beta 1.38
% of Institutional Shareholders 0.05%

Growth:

1-Year Return -55.49%
3-Year Return -69.86%
5-Year Return 84.78%
5-Year Revenue Growth 0.00%

Per-Share Information:

Latest Earnings Date 06/11/24
Earnings Per Share ttm -0.13
EPS Growth vs. Prev Year 30.00%
Dividend Payout Ratio 0.00%

SVA.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -183.58%
Return-on-Assets % -124.29%
Profit Margin % 0.00%
Debt/Equity N/A
Price/Sales N/A
Price/Book 33.64
Book Value/Share 0.01
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar